During FHE2025, the FHE Special Forum on "Exploration and Utilization of Probiotic Resources," hosted by Wecare Probiotics, concluded successfully.

Boao, Hainan, China – February 21, 2025 – At the "Wecare Night" event held on February 18th at the Boao International Convention Center, Wecare Probiotics hosted a grand celebration, illuminating the evening with a vibrant atmosphere.

At the recently concluded 10th Intestinal Microbiome and Health Symposium, Dr. JianGuo Zhu from Wecare Probiotics Institute delivered a compelling keynote speech titled "Screening and Process Optimization of Industrialized Functional Probiotic Strains." The symposium, held in Shanghai from December 20-21, brought together leading experts, researchers, and industry professionals to discuss the latest advancements and future trends in intestinal microbiome research.

the Wecare Probiotics Research Institute has made a groundbreaking discovery regarding the benefits of Weizmannia coagulans BC99 in improving human strength, facilitating protein digestion, and increasing skeletal muscle content. The clinical research results, which have been published in the prestigious medical journal Nutrients, offer a novel solution for athletes and the elderly population to enhance their athletic performance and nutritional intake through the use of probiotics.

Wecare has achieved industrial-scale production of this cutting-edge "weight management probiotic" in China, with an impressive annual Raw Material production capacity of 200 tons, marking a significant milestone in the global probiotics industry.